Literature DB >> 15761000

Recent developments in asthma management.

Graeme P Currie1, Graham S Devereux, Daniel K C Lee, Jon G Ayres.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15761000      PMCID： PMC554036          DOI： 10.1136/bmj.330.7491.585

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  41 in total

1.  Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial.

Authors:  P M O'Byrne; P J Barnes; R Rodriguez-Roisin; E Runnerstrom; T Sandstrom; K Svensson; A Tattersfield
Journal:  Am J Respir Crit Care Med       Date:  2001-10-15       Impact factor: 21.405

2.  Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.

Authors:  Graeme P Currie; Daniel K C Lee; Kay Haggart; Caroline E Bates; Brian J Lipworth
Journal:  Am J Respir Crit Care Med       Date:  2002-11-27       Impact factor: 21.405

3.  Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling.

Authors:  Michael Roth; Peter R A Johnson; Jochen J Rüdiger; Gregory G King; Qi Ge; Janette K Burgess; Gary Anderson; Michael Tamm; Judith L Black
Journal:  Lancet       Date:  2002-10-26       Impact factor: 79.321

4.  British guideline on the management of asthma.

Authors: 
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

5.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

Authors:  Ruth H Green; Christopher E Brightling; Susan McKenna; Beverley Hargadon; Debbie Parker; Peter Bradding; Andrew J Wardlaw; Ian D Pavord
Journal:  Lancet       Date:  2002-11-30       Impact factor: 79.321

6.  A randomized controlled trial of intravenous montelukast in acute asthma.

Authors:  Carlos A Camargo; Howard A Smithline; Marie-Pierre Malice; Stuart A Green; Theodore F Reiss
Journal:  Am J Respir Crit Care Med       Date:  2002-11-27       Impact factor: 21.405

7.  IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial.

Authors:  Robert A Silverman; Harold Osborn; Jeffrey Runge; E John Gallagher; William Chiang; James Feldman; Theodore Gaeta; Katherine Freeman; Bruce Levin; Noel Mancherje; Steven Scharf
Journal:  Chest       Date:  2002-08       Impact factor: 9.410

Review 8.  Chronic obstructive pulmonary disease * 9: management of ventilatory failure in COPD.

Authors:  P K Plant; M W Elliott
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

9.  Effects of fluticasone plus salmeterol versus twice the dose of fluticasone in asthmatic patients.

Authors:  Graeme P Currie; Caroline E Bates; Daniel K C Lee; Catherine M Jackson; Brian J Lipworth
Journal:  Eur J Clin Pharmacol       Date:  2003-03-22       Impact factor: 2.953

10.  Effects of mediator antagonism on mannitol and adenosine monophosphate challenges.

Authors:  G P Currie; K Haggart; D K C Lee; S J Fowler; A M Wilson; J D Brannan; S D Anderson; B J Lipworth
Journal:  Clin Exp Allergy       Date:  2003-06       Impact factor: 5.018
View more
  6 in total

1.  How does patients' quality of life guide their preferences regarding aspects of asthma therapy?: a patient-preference study using discrete-choice experiment methodology.

Authors:  Andrew Lloyd; Emma McIntosh; Angela E Williams; Ad Kaptein; Klaus F Rabe
Journal:  Patient       Date:  2008-12-01       Impact factor: 3.883

2.  A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART.

Authors:  Carol E Golin; Joanne Earp; Hsiao-Chuan Tien; Paul Stewart; Carol Porter; Lynn Howie
Journal:  J Acquir Immune Defic Syndr       Date:  2006-05       Impact factor: 3.731

3.  Updates on the Management of Severe Asthma.

Authors:  Atif Siddiqui; Lisa Kopas
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Apr-Jun

4.  Paper stamp checklist tool enhances asthma guidelines knowledge and implementation by primary care physicians.

Authors:  P M Renzi; H Ghezzo; S Goulet; E Dorval; R L Thivierge
Journal:  Can Respir J       Date:  2006 May-Jun       Impact factor: 2.409

5.  A novel nanogel loaded with chitosan decorated bilosomes for transdermal delivery of terbutaline sulfate: artificial neural network optimization, in vitro characterization and in vivo evaluation.

Authors:  Shahira F El Menshawe; Heba M Aboud; Mohammed H Elkomy; Rasha M Kharshoum; Amany M Abdeltwab
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

6.  Patient-centered care and its effect on outcomes in the treatment of asthma.

Authors:  Nashmia Qamar; Andrea A Pappalardo; Vineet M Arora; Valerie G Press
Journal:  Patient Relat Outcome Meas       Date:  2011-03-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.